Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE) to current standard-of-care first ...

Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...

Every year, over 20 million people globally are diagnosed with cancer and close to 9.5 million people will reportedly succumb ...

Plexus Worldwide, a leading health and wellness company, reaffirms its unwavering commitment to supporting breast cancer awareness and research during Breast Cancer Awareness Month (BCAM).

Rosamund Dean, who was diagnosed with stage three breast cancer in April 2019, has spoken out about a little-known side ...

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...